Lenvatinib in multimodal therapy for unresectable radioactive iodine-naïve differentiated thyroid cancer: A case report with literature review.

Hugh Andrew Jinwook Kim Anthony Charles NicholsRamanamurthy RachakondaRichard InculetJinka SathyaIrina RachinskyEric Winquist

Published in: Cancer reports (Hoboken, N.J.) (2022)

Lenvatinib may be effective in RAI-naïve advanced DTC patients as a component of individualized multimodal therapy when conventional options are not feasible.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
pain management
peritoneal dialysis
stem cells
squamous cell carcinoma
computed tomography
patient reported outcomes
chronic pain
rectal cancer
patient reported